Home NDC 72162-2558 Repaglinide
Product NDC 72162-2558
11-digit product format 721622558
Labeler code 72162
Product ID 72162-2558_481210ad-ee08-453c-b79f-27f4a8777d94
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Repaglinide
Dosage form TABLET
Route ORAL
Labeler Bryant Ranch Prepack
Application ANDA203820
Marketing category ANDA
Marketing start 2014-01-22
Substance REPAGLINIDE
Active strength 1 mg/1
Pharmacologic classes Glinide [EPC], Potassium Channel Antagonists [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A203820-001 REPAGLINIDE REPAGLINIDE 0.5MG TABLET / ORAL AB 2014-01-22 A203820-002 REPAGLINIDE REPAGLINIDE 1MG TABLET / ORAL AB 2014-01-22 A203820-003 REPAGLINIDE REPAGLINIDE 2MG TABLET / ORAL AB RS 2014-01-22
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 123 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A203820-001 REPAGLINIDE 0.5MG TABLET / ORAL AB 2014-01-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A203820-002 REPAGLINIDE 1MG TABLET / ORAL AB 2014-01-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A203820-003 REPAGLINIDE 2MG TABLET / ORAL AB RS 2014-01-22 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203820-001 REPAGLINIDE 0.5MG TABLET / ORAL AB 2014-01-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203820-002 REPAGLINIDE 1MG TABLET / ORAL AB 2014-01-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203820-003 REPAGLINIDE 2MG TABLET / ORAL AB RS 2014-01-22 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A203820-001 REPAGLINIDE 0.5MG TABLET / ORAL AB 2014-01-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A203820-002 REPAGLINIDE 1MG TABLET / ORAL AB 2014-01-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A203820-003 REPAGLINIDE 2MG TABLET / ORAL AB RS 2014-01-22 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203820-001 REPAGLINIDE 0.5MG TABLET / ORAL AB 2014-01-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203820-002 REPAGLINIDE 1MG TABLET / ORAL AB 2014-01-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203820-003 REPAGLINIDE 2MG TABLET / ORAL AB RS 2014-01-22 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203820-001 REPAGLINIDE 0.5MG TABLET / ORAL AB 2014-01-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203820-002 REPAGLINIDE 1MG TABLET / ORAL AB 2014-01-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203820-003 REPAGLINIDE 2MG TABLET / ORAL AB RS 2014-01-22 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A203820-001 REPAGLINIDE 0.5MG TABLET / ORAL AB 2014-01-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A203820-002 REPAGLINIDE 1MG TABLET / ORAL AB 2014-01-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A203820-003 REPAGLINIDE 2MG TABLET / ORAL AB RS 2014-01-22 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A203820-001 REPAGLINIDE 0.5MG TABLET / ORAL AB 2014-01-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A203820-002 REPAGLINIDE 1MG TABLET / ORAL AB 2014-01-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A203820-003 REPAGLINIDE 2MG TABLET / ORAL AB RS 2014-01-22 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A203820-001 REPAGLINIDE 0.5MG TABLET / ORAL AB 2014-01-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A203820-002 REPAGLINIDE 1MG TABLET / ORAL AB 2014-01-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A203820-003 REPAGLINIDE 2MG TABLET / ORAL AB RS 2014-01-22 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A203820-001 REPAGLINIDE 0.5MG TABLET / ORAL AB 2014-01-22 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A203820-002 REPAGLINIDE 1MG TABLET / ORAL AB 2014-01-22 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A203820-003 REPAGLINIDE 2MG TABLET / ORAL AB RS 2014-01-22 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A203820-001 REPAGLINIDE 0.5MG TABLET / ORAL AB 2014-01-22 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A203820-002 REPAGLINIDE 1MG TABLET / ORAL AB 2014-01-22 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A203820-003 REPAGLINIDE 2MG TABLET / ORAL AB RS 2014-01-22 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A203820-001 REPAGLINIDE 0.5MG TABLET / ORAL AB 2014-01-22 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A203820-002 REPAGLINIDE 1MG TABLET / ORAL AB 2014-01-22 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A203820-003 REPAGLINIDE 2MG TABLET / ORAL AB RS 2014-01-22 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A203820-001 REPAGLINIDE 0.5MG TABLET / ORAL AB 2014-01-22 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A203820-002 REPAGLINIDE 1MG TABLET / ORAL AB 2014-01-22 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A203820-003 REPAGLINIDE 2MG TABLET / ORAL AB RS 2014-01-22 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A203820-001 REPAGLINIDE 0.5MG TABLET / ORAL AB 2014-01-22 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A203820-002 REPAGLINIDE 1MG TABLET / ORAL AB 2014-01-22 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A203820-003 REPAGLINIDE 2MG TABLET / ORAL AB RS 2014-01-22 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A203820-001 REPAGLINIDE 0.5MG TABLET / ORAL AB 2014-01-22 8072bd15b7f6…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 123 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Repaglinide
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength REPAGLINIDE 1 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 668Z8C33LU Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 200256 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 72162-2558-1 Repaglinide 100 in 1 BOTTLE TABLET 100 100
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 5 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 72162-2558-1 72162255801 100 TABLET in 1 BOTTLE (72162-2558-1) 100 tablet 2025-11-04 No No Current